165 related articles for article (PubMed ID: 29531835)
1.
Weng Y; Fan X; Bai Y; Wang S; Huang H; Yang H; Zhu J; Zhang F
Cell Death Discov; 2018 Dec; 4():38. PubMed ID: 29531835
[TBL] [Abstract][Full Text] [Related]
2. Fructose utilization enhanced by GLUT5 promotes lung cancer cell migration via activating glycolysis/AKT pathway.
Yang J; Dong C; Wu J; Liu D; Luo Q; Jin X
Clin Transl Oncol; 2023 Apr; 25(4):1080-1090. PubMed ID: 36454516
[TBL] [Abstract][Full Text] [Related]
3. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling.
Chen WL; Jin X; Wang M; Liu D; Luo Q; Tian H; Cai L; Meng L; Bi R; Wang L; Xie X; Yu G; Li L; Dong C; Cai Q; Jia W; Wei W; Jia L
JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051337
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A inhibits expression of the human SLC2A5 gene via SNAI1/SNAI2 transcription factors and sensitizes colon cancer cells to platinum compounds.
Chałaśkiewicz K; Karaś K; Zakłos-Szyda M; Karwaciak I; Pastwińska J; Koziołkiewicz M; Ratajewski M
Eur J Pharmacol; 2023 Jun; 949():175728. PubMed ID: 37062501
[TBL] [Abstract][Full Text] [Related]
5. GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase.
Liang RJ; Taylor S; Nahiyaan N; Song J; Murphy CJ; Dantas E; Cheng S; Hsu TW; Ramsamooj S; Grover R; Hwang SK; Ngo B; Cantley LC; Rhee KY; Goncalves MD
Cancer Metab; 2021 Mar; 9(1):12. PubMed ID: 33762003
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.
Chen WL; Wang YY; Zhao A; Xia L; Xie G; Su M; Zhao L; Liu J; Qu C; Wei R; Rajani C; Ni Y; Cheng Z; Chen Z; Chen SJ; Jia W
Cancer Cell; 2016 Nov; 30(5):779-791. PubMed ID: 27746145
[TBL] [Abstract][Full Text] [Related]
7. GLUT5 increases fructose utilization in ovarian cancer.
Jin C; Gong X; Shang Y
Onco Targets Ther; 2019; 12():5425-5436. PubMed ID: 31371983
[No Abstract] [Full Text] [Related]
8. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma.
Jin X; Liang Y; Liu D; Luo Q; Cai L; Wu J; Jia L; Chen WL
Cell Biol Toxicol; 2019 Oct; 35(5):471-483. PubMed ID: 31102011
[TBL] [Abstract][Full Text] [Related]
9. SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia.
Zhao P; Huang J; Zhang D; Zhang D; Wang F; Qu Y; Guo T; Qin Y; Wei J; Niu T; Zheng Y
Br J Haematol; 2018 Oct; 183(2):242-250. PubMed ID: 30272826
[TBL] [Abstract][Full Text] [Related]
10. GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.
Shen Z; Li Z; Liu Y; Li Y; Feng X; Zhan Y; Lin M; Fang C; Fang Y; Deng H
Cancer Lett; 2022 May; 534():215617. PubMed ID: 35257833
[TBL] [Abstract][Full Text] [Related]
11. Diet-induced epigenetic regulation in vivo of the intestinal fructose transporter Glut5 during development of rat small intestine.
Suzuki T; Douard V; Mochizuki K; Goda T; Ferraris RP
Biochem J; 2011 Apr; 435(1):43-53. PubMed ID: 21222652
[TBL] [Abstract][Full Text] [Related]
12. Gene variants of the SLC2A5 gene encoding GLUT5, the major fructose transporter, do not contribute to clinical presentation of acquired fructose malabsorption.
Taneva I; Grumann D; Schmidt D; Taneva E; von Arnim U; Ansorge T; Wex T
BMC Gastroenterol; 2022 Apr; 22(1):167. PubMed ID: 35387598
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Fructose Transporter Gene
Mizuno TM; Lew PS; Jhanji G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884473
[TBL] [Abstract][Full Text] [Related]
14. Targeting fructose metabolism by glucose transporter 5 regulation in human cholangiocarcinoma.
Suwannakul N; Armartmuntree N; Thanan R; Midorikawa K; Kon T; Oikawa S; Kobayashi H; Ma N; Kawanishi S; Murata M
Genes Dis; 2022 Nov; 9(6):1727-1741. PubMed ID: 36157482
[TBL] [Abstract][Full Text] [Related]
15. GLUT5 increases fructose utilization and promotes tumor progression in glioma.
Su C; Li H; Gao W
Biochem Biophys Res Commun; 2018 Jun; 500(2):462-469. PubMed ID: 29660339
[TBL] [Abstract][Full Text] [Related]
16. [The Roles of Glut5 in Imatinib Resistance in the Ph
Yan TY; Naren DL; Gong YP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):389-393. PubMed ID: 28616912
[TBL] [Abstract][Full Text] [Related]
17. Loss of the fructose transporter SLC2A5 inhibits cancer cell migration.
Groenendyk J; Stoletov K; Paskevicius T; Li W; Dai N; Pujol M; Busaan E; Ng HH; Boukouris AE; Saleme B; Haromy A; Cui K; Hu M; Yan Y; Zhang R; Michelakis E; Chen XZ; Lewis JD; Tang J; Agellon LB; Michalak M
Front Cell Dev Biol; 2022; 10():896297. PubMed ID: 36268513
[TBL] [Abstract][Full Text] [Related]
18. ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome.
Oh AR; Sohn S; Lee J; Park JM; Nam KT; Hahm KB; Kim YB; Lee HJ; Cha JY
Metabolism; 2018 Aug; 85():286-297. PubMed ID: 29669261
[TBL] [Abstract][Full Text] [Related]
19. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
20. Fructose-responsive genes in the small intestine of neonatal rats.
Cui XL; Soteropoulos P; Tolias P; Ferraris RP
Physiol Genomics; 2004 Jul; 18(2):206-17. PubMed ID: 15150374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
